NCT01654120View on ClinicalTrials.gov

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

Liraglutide

SC, 1.8mg,QD, six months to one year

DRUG

Insulin

SC, will be titrated during the study, 4 times a day, 1 year

Trial Locations (1)

28803

Mountain Diabetes and Endocrine Center, Asheville

All Listed Sponsors
lead

Mountain Diabetes and Endocrine Center

OTHER

NCT01654120 - Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics | Biotech Hunter | Biotech Hunter